• Filing Date: 2018-05-15
  • Form Type: 10-Q
  • Description: Quarterly report
v3.8.0.1
KFBV Loans and Derivative Liability Disclosure (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2015
Dec. 31, 2017
Dec. 17, 2015
Sep. 08, 2014
Jul. 28, 2014
Mar. 10, 2014
Jan. 15, 2014
Accretion expense   $ 1,046,271              
Financing costs   362,720              
First KF Business Ventures Loan Agreement                  
Loan agreement                 $ 2,000,000
Common stock that may be exercised by warrants           2,350,000   6,904,546  
Exercise price per warrant share         $ 0.10 $ 0.50   $ 1.00  
Interest expense recorded $ 114,025 82,167              
Accretion expense   73,250              
Derivative liability 74,336     $ 53,439          
Second KF Business Ventures Loan Agreement                  
Loan agreement             $ 2,400,000    
Common stock that may be exercised by warrants         1,337,320   9,600,000    
Exercise price per warrant share         $ 0.10   $ 0.50    
Interest expense recorded 125,736 92,004              
Accretion expense   165,212              
Derivative liability 77,899     56,024          
Third KF Business Ventures Loan Agreement                  
Loan agreement         $ 1,500,000        
Common stock that may be exercised by warrants         8,000,000        
Exercise price per warrant share         $ 0.10        
Interest expense recorded 71,190 51,300              
Accretion expense   $ 807,809              
Third KF Warrants                  
Derivative liability 64,000     48,000          
Third KF Loan Conversion Feature                  
Derivative liability 2,157,362     $ 1,968,174          
KF Business Ventures Deferred Financing Costs                  
Legal Fees     $ 50,538            
Financing costs $ 564